Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases.
Transforming growth factor β (TGF-β) is a powerful promoter of cancer progression and a key target for antitumor therapy. As cancer cells exhibit active cholesterol metabolism, high density lipoproteins (HDLs) appear as an attractive delivery system for anticancer TGFβ-inhibitory molecules. We const...
| 出版年: | PLoS ONE |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Public Library of Science (PLoS)
2014-01-01
|
| オンライン・アクセス: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096799&type=printable |
